Sullivan, Bruyette, Speros & Blaney’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$200K Buy
4,296
+805
+23% +$35.6K 0.01% 308
2020
Q4
$135K Sell
3,491
-53
-1% -$1.89K 0.01% 345
2020
Q3
$102K Buy
+3,544
New +$99.8K 0.01% 344
2020
Q1
Sell
-4,251
Closed -$126K 306
2019
Q4
$126K Buy
4,251
+281
+7% +$7.44K 0.01% 309
2019
Q3
$111K Buy
+3,970
New +$115K 0.01% 316

Other funds holding CTVA

Sullivan, Bruyette, Speros & Blaney's CTVA Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Corteva (CTVA) stake by 23% in Q1 2021, buying an estimated $35.6K and bringing the position to 4,296 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #308.

Sullivan, Bruyette, Speros & Blaney first reported a position in CTVA in Q3 2019 and has held it in 5 quarters since. 1,079 funds tracked by Wall St. Rank hold CTVA as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 4,296 shares of Corteva worth $200K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 805 Corteva shares in Q1 2021, an estimated $35.6K.
  • Corteva made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #308 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Corteva in Q3 2019 and has held it in 5 quarters since.
  • 1,079 funds tracked by Wall St. Rank held Corteva as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.